- ourpublicrecords.org/criminal/records
AnnonceCriminal Records Lookup 2023 - 1) Enter Any Name & State
ourpublicrecords.org a été visité par plus de 10 000 utilisateurs le mois dernier
Look Up Anyone You Know to See If They Have a Criminal Record. Even Look Up Yourself! You Never Know Who Might Have a Serious Criminal Past. All Searches Are 100% Private.
- Death Records
Instantly Search Death Records
Find The Records You Need Now
- Public Records
Easy And Quick Access
Thorough & Substantial Reviews
- Search Marriage Records
Marriage & Divorce Records
Uncover Hidden Information
- Public Records Online
Access Millions Of Records Online
& Reveal Almost Anyone's Public ...
- Marriage Records
Search For Marriage Records
Uncover The Records You Need Now
- Discover Obituary Records
Lookup Any obituary
Uncover The Records You Need
- Death Records
Résultats de recherche
5 déc. 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
- PMC7856571
The ARREST trial began on Aug 8, 2019, and was terminated...
- PMC7856571
27 août 2023 · The ARREST trial is an investigator-led, prospective, parallel, multicentre, open-label, randomised superiority trial in which expedited transfer to a cardiac arrest centre was compared with current standard of care, comprising patient transfer to the geographically closest emergency department following resuscitated OHCA.
- Clinical Question
- Background
- Design
- Setting
- Population
- Outcome
- Authors’ Conclusions
- Strengths
- Weaknesses
- The Bottom Line
In adults suffering out of hospital cardiac arrest (OHCA) presenting with an initial rhythm of VF or pulseless VT, does the implementation of early ECMO facilitated resuscitation compared to standa...
OHCA has a well documented poor survival rateHalf of all patients with VF and OHCA have refractory VF which has a much worse prognosisThe evidence for the use of ECMO in OHCA is from observational cohort studies with no randomised trials to dateThe 2CHEERtrial published this year (both OHCA and IHCA with presumed cardio-respiratory origin), showed 44% of patients had survival to hospital discharge with a favourable neurological outcomePhase 2, single centre, open-label RCTOn hospital arrival, member of study team would verify eligibility and randomisation would occurFunctional assessment at 3 and 6 months done by qualified assessors blinded to group allocationPre-specified secondary outcomes included:University of Minnesota Medical Center, USAAugust 2019 – June 2020Inclusion:Exclusion:36 patients assessed > 30 patients enrolled and randomly assigned (15 in each arm)Baseline Demographics similar (ECMO v ACLS)Primary outcome:Secondary outcomes:Adverse Events:Early ECMO-facilitated resuscitation for patients with OHCA and refractory VF significantly improved survival to hospital discharge when compared to standard ACLS treatment
Well done randomised trial in a logistically complex cohort of patientsAnalysed on ITT basisExcellent safety reporting measuresThe statistical plan for randomisation ratios seems complex but given the evidence base prior surrounding ECMO and its improved survival rates then the protocol to continually adapt the numbers of...Single center study reduces external validitySmall numbers of patientsIt would be interesting to see the breakdown of CPC scoresNo cost analysis done despite being one of the listed secondary outcomes on the trial protocolThis randomised trial showed early initiation ECMO resulted in an impressive 43% survival to hospital discharge for refractory shockable OHCAThe numbers involved were small, and this study was carried out in a centre that was experienced. It is therefore important for other centres to consider their expertise, local protocols and transp...Further randomised work is being carried out (e.g. INCEPTION trial) and the results of these ongoing studies should provide a bigger evidence base to inform practiceI would advocate for the ongoing use of early ECMO in this patient cohort given the poor survival rates for standard ACLS3 juil. 2021 · The ARREST trial was a phase 2, single-centre, open-label, adaptive, safety and efficacy randomised clinical trial comparing early extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation to standard advanced cardiac life support (ACLS) in adults with out-of-hospital refractory ventricular fibrillation cardiac arrest.
- Jason A Bartos, Demetris Yannopoulos
- 2021
25 janv. 2023 · The ARREST trial was terminated early because of superiority of the intervention: survival to discharge occurred in 6 of 14 patients (43%) in the group that received extracorporeal CPR as...
13 nov. 2020 · To our knowledge, the ARREST trial is the first randomised interventional trial to assess the effect of early ECMO-facilitated resuscitation compared with standard ACLS treatment for survival of patients with out-of-hospital refractory cardiac arrest. The results showed that, in a well organised and experienced system, survival for ...
18 mars 2019 · The most frequent cause of cardiac arrest is ischemic heart disease, and coronary artery disease has been reported in up to 70% of patients who have been resuscitated and are referred for...